Monotherapy for partial onset seizure w/ or w/o secondary generalisation in adults & adolescents ≥16 yr w/ newly diagnosed epilepsy. Add-on to other antiepileptic medicines for partial onset seizures w/ or w/o generalisation in adults, adolescents, childn & infants ≥1 mth of age; myoclonic seizures in adults & adolescents ≥12 yr w/ juvenile myoclonic epilepsy; primary generalised tonic-clonic seizures in adults & adolescents ≥12 yr w/ idiopathic generalised epilepsy.
Growth retardation or unexpected puberty development in childn; symptoms of depression &/or suicidal ideation; family or medical history of irregular heart rhythm; disease &/or treatment that makes patient prone to heart irregularities or salt imbalances; worsened or increased frequency of seizures during the 1st mth of therapy or w/ dose increase. May impair ability to drive or operate any tools or machinery. Contains methyl parahydroxybenzoate; propylene glycol. Patients w/ intolerance to sugars; controlled Na diet; kidney problems. Can be used during pregnancy only if considered necessary. Breast-feeding is not recommended during treatment. Not indicated for monotherapy in childn & adolescent <16 yr.
Sign Out
